The World Health Organization said it was impatient on Wednesday to analyze the results of clinical trials of "Sputnik V", the Russian vaccine against the coronavirus. If it proves to be "effective", the WHO pleads for "rapid, fair and equitable access worldwide to such a vaccine".

The World Health Organization (WHO) said on Wednesday it looked forward to analyzing the results of clinical trials of the vaccine against the new coronavirus, which President Vladimir Putin announced the day before in Russia.

>> LIVE - Coronavirus: follow the evolution of the situation Wednesday August 12 

"Rapid, fair and equitable access worldwide to such a vaccine"

The final phase of testing of this product, in which more than 2,000 people in total will participate, was to begin on Wednesday, the Russian president said at the time. "The WHO is in contact with the scientists and the Russian authorities and looks forward to studying the details of the clinical trials," reads the press release issued in Geneva, where the organization is headquartered. "Speeding up research to obtain a vaccine should be done by following established processes at each stage of development, to ensure that any vaccine that is ultimately produced is both safe and effective," the WHO continues, urging "rapid, fair and equitable access worldwide to such a vaccine".

CORONAVIRUS ESSENTIALS

> Coronavirus: three questions on rapid serological tests in pharmacies

> Holidays: should grandparents worry about looking after their grandchildren?

> Coronavirus: in schools, the health protocol will remain the same at the start of the school year

> Coronavirus: the 5 mistakes not to make with your mask

> Coronavirus: what we know about transmission by micro-droplets in the air

The World Health Organization reacted cautiously on Tuesday to Vladimir Putin's announcement, recalling that the "prequalification" and approval of a vaccine went through "rigorous" procedures. So far, Russia has not released detailed studies of the results of its trials to establish the effectiveness of the products it says it has created.